Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Stoppa-Lyonnet

Showing results (31-40 of 350) with videos related to

Pageof 35
Sort By:
Breast (Edinburgh, Scotland)|March 2, 2019
"Decoding hereditary breast cancer" benefits and questions from multigene panel testingChrystelle Colas, Lisa Golmard, Antoine de Pauw, et al.
Presse Medicale (Paris, France : 1983)|September 25, 2019
[Familial disclosure by healthcare professionals in absence of genetic mutation]Antoine de Pauw, Benjamin Derbez, Chrystelle Colas, et al.
American Journal of Clinical Oncology|March 25, 2009
Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations statusAlain Fourquet, Dominique Stoppa-Lyonnet, Youlia M Kirova, et al.
Familial Cancer|May 8, 2004
BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effectDanièle Muller, Catherine Bonaiti-Pellié, Joseph Abecassis, et al.
Human Molecular Genetics|October 24, 2002
The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codonsLaure Perrin-Vidoz, Olga M Sinilnikova, Dominique Stoppa-Lyonnet, et al.
Bulletin Du Cancer|May 30, 2012
[Perception accuracy of BRCA1/2 mutation predisposition in breast cancer women and associated factors]Débora Leblond, Anne Brédart, Sylvie Dolbeault, et al.
Bulletin Du Cancer|June 20, 2017
Laurence Gladieff, Dominique Stoppa Lyonnet, Alain Lortholary, et al.
Bulletin Du Cancer|February 25, 2012
[Hereditary forms of ovarian cancer]Antoine de Pauw, Laurianne Jolissaint, Paul Fréneaux, et al.
International Journal of Cancer|May 7, 2002
Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factorsBéatrice Geoffroy-Perez, Nicolas Janin, Katia Ossian, et al.
Genome Biology|November 12, 2009
Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arraysTatiana Popova, Elodie Manié, Dominique Stoppa-Lyonnet, et al.
Pageof 35

Showing results (31-40 of 350) with videos related to

Sort By:
Pageof 35
Breast (Edinburgh, Scotland)|March 2, 2019
"Decoding hereditary breast cancer" benefits and questions from multigene panel testingChrystelle Colas, Lisa Golmard, Antoine de Pauw, et al.
Presse Medicale (Paris, France : 1983)|September 25, 2019
[Familial disclosure by healthcare professionals in absence of genetic mutation]Antoine de Pauw, Benjamin Derbez, Chrystelle Colas, et al.
American Journal of Clinical Oncology|March 25, 2009
Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations statusAlain Fourquet, Dominique Stoppa-Lyonnet, Youlia M Kirova, et al.
Familial Cancer|May 8, 2004
BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effectDanièle Muller, Catherine Bonaiti-Pellié, Joseph Abecassis, et al.
Human Molecular Genetics|October 24, 2002
The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codonsLaure Perrin-Vidoz, Olga M Sinilnikova, Dominique Stoppa-Lyonnet, et al.
Bulletin Du Cancer|May 30, 2012
[Perception accuracy of BRCA1/2 mutation predisposition in breast cancer women and associated factors]Débora Leblond, Anne Brédart, Sylvie Dolbeault, et al.
Bulletin Du Cancer|June 20, 2017
Laurence Gladieff, Dominique Stoppa Lyonnet, Alain Lortholary, et al.
Bulletin Du Cancer|February 25, 2012
[Hereditary forms of ovarian cancer]Antoine de Pauw, Laurianne Jolissaint, Paul Fréneaux, et al.
International Journal of Cancer|May 7, 2002
Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factorsBéatrice Geoffroy-Perez, Nicolas Janin, Katia Ossian, et al.
Genome Biology|November 12, 2009
Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arraysTatiana Popova, Elodie Manié, Dominique Stoppa-Lyonnet, et al.
Pageof 35